AHUS

Clinical trials for AHUS explained in plain language.

Never miss a new study

Get alerted when new AHUS trials appear

Sign up with your email to follow new studies for AHUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug ravulizumab aims to control rare blood disorder aHUS

Disease control Recruiting now

This study is testing the drug ravulizumab in 20 people with atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and kidney damage. The goal is to see if the drug improves platelet counts and kidney function over 26 weeks. All participants receive …

Matched conditions: AHUS

Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

AHUS

Get alerted when new AHUS trials appear

New drug ravulizumab aims to control rare blood disorder aHUS